5:1 Reverse Stock Split Decision, Capital Decrease of 1,000 Won


  • Reverse stock split ratio of 5:1 (par value from 500 KRW to 2,500 KRW), reducing total outstanding shares from 30,979,827 to 6,195,965
  • Capital decrease of 1,000 KRW due to fractional share handling (pre-split: 15,489,913,500 KRW, post-split: 15,489,912,500 KRW)
  • Purpose: stabilize stock price and enhance corporate value by maintaining an appropriate number of outstanding shares
  • Key schedule: General shareholders' meeting on 2026-07-06, effective date for new shares on 2026-08-07, listing date for new shares on 2026-08-27
  • Trading suspension period: from 2026-08-05 to 2026-08-26

KOSDAQ Filing Information


  • Filing: Stock Merger Decision
  • Company: ChoA Pharmaceutical (034940)
  • Submission: ChoA Pharmaceutical Co., LTD.
  • Receipt: 05-22-2026
  • Under KRX KOSDAQ Market Division